Bleichroeder LP’s CareDx CDNA Stock Holding History

Bleichroeder LP’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-125,000	Closed	-$4.74M	–	74
2020 Q3	$4.74M	Hold	125,000	–	–	0.85%	25
2020 Q2	$4.43M	Buy	125,000 +25,000	+25%	+$711K	0.78%	26
2020 Q1	$2.18M	Hold	100,000	–	–	0.57%	30
2019 Q4	$2.16M	Buy	+100,000	New	+$2.29M	0.34%	30

Other funds holding CDNA

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bleichroeder LP's CDNA Position: Q4 2020 in Review

Bleichroeder LP sold out of CareDx (CDNA) in Q4 2020, closing a stake of 125,000 shares — an estimated $4.74M sold.

Bleichroeder LP first reported a position in CDNA in Q4 2019 and held it in 4 quarters. The position peaked at $4.74M in Q3 2020. 233 funds tracked by Wall St. Rank hold CDNA as of Q4 2020.

Bleichroeder LP reported no remaining CareDx position as of Q4 2020 after selling out during the quarter.
Bleichroeder LP sold 125,000 CareDx shares in Q4 2020, an estimated $4.74M.
Bleichroeder LP first reported a position in CareDx in Q4 2019 and held it in 4 quarters.
Bleichroeder LP's CareDx position peaked at $4.74M in Q3 2020.
233 funds tracked by Wall St. Rank held CareDx as of Q4 2020.

Based on Bleichroeder LP's 13F filing for Q4 2020, filed 10 Feb 2021.